|
Table 2: Clinical and laboratory findings in studied SLE population |
||
|
Items |
No |
% |
|
|
|
|
|
Mucocutanous manifestations |
|
|
|
Malar rash |
54 |
91.5 |
|
Discoid rash |
12 |
20.3 |
|
Photosensitivity |
49 |
83.1 |
|
Oral ulcers |
50 |
84.7 |
|
|
|
|
|
Arthritis |
31 |
52.5 |
|
|
|
|
|
Serositis (pleurisy, pericardium rub) |
26 |
44.1 |
|
|
|
|
|
Renal findings |
|
|
|
Non |
7 |
11..9 |
|
Persistent proteinuria >0.5 grams/day or greater than 3+ |
6 |
10.2 |
|
Cellular casts |
14 |
23.7 |
|
Both |
32 |
54.2 |
|
|
|
|
|
Neuropsychiatric manifestations |
|
|
|
Non |
41 |
69.5 |
|
Seizures |
10 |
16.9 |
|
Psychosis |
1 |
1.7 |
|
Persistence unexplained headache |
7 |
11.9 |
|
|
|
|
|
Hematological manifestations |
|
|
|
No |
3 |
5.1 |
|
Anemia |
30 |
50.8 |
|
Leucopenia (<4000/mm) |
33 |
55.9 |
|
Lymphopenia (<1500/mm) |
3 |
5.1 |
|
Thrombocytopenia (<100.000/mm) |
20 |
33.9 |
|
Anti-DNA & anti-phospholipids Abs negative |
12 |
20.3 |
|
Anti-DNA Abs positive |
43 |
72.9 |
|
Anti-DNA & anti-phospholipids Abs positive |
4 |
6.8 |
|
ANA positive |
59 |
100 |